Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Nocardia sp" patented technology

Novel antibiotic Chemomycin A and preparation method thereof

The invention discloses a new Chemomycin A and preparing method and drug component and application in the tumour prevention drug, which is characterized by the following: separating Angucycline from Nocardia Mediterranei Var. Kanglensis 1747-64 to obtain the product; displaying excellent anti-tumour activity in the external activity test.
Owner:MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI

Nocardia sp. capable of converting quininone into (R)-3-quinuclidinol and conversion method

The invention discloses a Nocardia sp. WY1202 and a production method for (R)-3-quinuclidinol through fermentation of quininone by using Nocardia sp. WY1202. According to the invention, quininone hydrochloride is used as a sole carbon source for the strain of Nocardia sp. WY1202 which is screened from soil in a farm orchard in Xiqing District, Tianjin City, China, and is preserved in China General Microbiological Collection Center with an accession number of CGMCC No. 5095. The production method comprises the following steps: with the Nocardia sp.WY1202 as a strain, carrying out primary seed culture and secondary fermentation amplification culture; taking a fermentation culture solution, collecting thalli through centrifugation, washing the thalli and re-suspending the thalli in a buffer solution; adding the substrate quininone hydrochloride, adding glucose and carrying out centrifugation after a reaction for 24 to 48 h; adjusting the pH value of a supernatant until the supernatant is alkaline; drying the supernatant through pressure reduced spinning; subjecting an obtained residue to solid-liquid extraction with an organic solvent; and drying an obtained filtrate through spinning so as to obtain (R)-(-)-3-quinuclidinol. According to the invention, the product (R)-(-)-3-quinuclidinol has a yield of 95%, a purity of 96% and an e.e value of more than 95%; the production method is simple to operate, has low energy consumption, accords with requirements for green chemistry and is applicable to large-scale bioconversion production for (R)-(-)-3-quinuclidinol.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Proteases

Disclosed are a high specific active protease congenetic with the protease from imitative Nocard's bacillus, and the production in the wild type and the reconstructed host-cells containing the transgenic plant and the no-human transgenic animal cells. The protease is effective in animal feed and washing agent. Peculiar structural characteristics related to the high specific activity of protease are also disclosed. The protease belongs to the peptidase family S2A or S1E.
Owner:NOVOZYMES AS

Novel antibiotic Chemomycin A, B, C, D and preparation method thereof

The present invention relates to a group of novel compound Chemomicin B,C,D and its preparation method, pharmaceutical composition containing Chemomicin B,C,D as active ingredients and its uses of Chemomicin B,C,D in preparing antineoplastic drug. Chemomicin B,C,D is Angucyclinone antibiotic separated from Nocardia Mediterranei Var.Kanglensis 1747-64 culture. In vitro activity test prove Chemomicin B,C,D has strong suppressing activity for human oesophagus cancer cell KYSE150 and has good development prospect as a novel antineoplastic drug.
Owner:MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI

Conversion method for euphorbia lathyris phorbol derivative and use thereof for preparing antitumor drug

The invention belongs to the technical field of the biological medicine, and relates to a microbial conversion method for a euphorbia lathyris diterpene compound. The method comprises the following steps: performing the microbial conversion to euphorbia lathyris phorbol and 7-hydroxy euphorbia lathyris phorbol by using Nocard's bacillus (i) Nocardia sp. ( / i) NRRL 5646, and preparing 3-carbonyl euphorbia lathyris phorbol and 7-acetoxyl euphorbia lathyris phorbol derivatives. Proved by the experiment, the polarity of the 3-carbonyl euphorbia lathyris phorbol in the derivative is reduced. Compared with a substrate, the derivative has the better cytotoxic activity. The derivative is an antitumor lead compound with development value.
Owner:FUDAN UNIV

Preparation method of Nocardia competent cells and gene editing method of Nocardia

The invention provides a preparation method of Nocardia competent cells and a gene editing method of Nocardia. According to the preparation method, Nocardia is treated with lysozyme so that the thickness of cellular wall of Nocardia is deceased; Nocardia competent cells easily accepting exogenous DNAs are finally prepared. The preparation method is simple and quick to perform and has high application value. A CRSIPR / Cas9 system is applied to Nocardia for the first time herein according to the gene editing method of Nocardia; a CRISPR / Cas9 genetic editing plasmid is constructed and is convertedand delivered to Nocardia for editing a target gene. The gene editing method is simple and quick to perform, has high application value and helps lay the basis for the study on gene functionality ofNocardia, the construction of gene deleted strains of Nocardia and the preparation of gene deleted vaccines of Nocardia.
Owner:SHENZHEN INST OF GUANGDONG OCEAN UNIV +2

Nocardiopsis for producing ansamycin P-3 and 15-hydroxyl derivatives as well as preparation method and application of nocardiopsis

The invention discloses an alkali-resisting nocardiopsis for producing ansamycin P-3 and 15-hydroxyl derivatives as well as a preparation method and the application of the nocardiopsis. The provided strain is nocardiopsis EGI 80425, and the collection number of the nocardiopsis EGI 80425 is CGMCC No. 9969; a good technical effect can be obtained in the application of the strain in preparing the ansamycin P-3 and the 15-hydroxyl derivatives thereof. Tests prove that a remarkable and obvious technical effect can be obtained in the application of the strain nocardiopsis EGI 80425 CGMCC No. 9969 in producing the ansamycin P-3 and the 15-hydroxyl derivatives thereof, and therefore, the strain has excellent application prospect in producing the ansamycin P-3 and the 15-hydroxyl derivatives thereof.
Owner:XINJIANG INST OF ECOLOGY & GEOGRAPHY CHINESE ACAD OF SCI +1

Rhodococcus pumilus bacteriophage P19 and application thereof

The invention discloses a rhodococcus circulans phage P19 and application thereof, and belongs to the technical field of biology. The preservation number of the nocardia pekinensis bacteriophage P19 disclosed by the invention is CGMCC No.23087. The nocardia pekinensis bacteriophage P19 provides a selectable basic material for prevention and control of a sludge foaming event caused by rhodococcus pluvialis, and enriches a bacteriophage seed bank; through separation identification and whole genome sequencing of the bacteriophage P19, functional genes and proteins of the bacteriophage P19 are further deeply excavated, and one or more enzymes and the like with a splitting effect on rhodococcus circulans are provided for bacteriophage treatment and biological prevention and treatment, so that a host spectrum is expanded, and the application universality and effectiveness of the bacteriophage are improved; the bacteriophage P19 can rapidly and efficiently split rhodococcus circulans, and can be used for sludge foaming events caused by excessive propagation of rhodococcus circulans in a sewage treatment system.
Owner:UNIVERSITY OF CHINESE ACADEMY OF SCIENCES

Chromogenic solid culture medium of nocardia seriolae as well as preparation method and application

ActiveCN112143682AFast growthIncrease survival competitive advantageBacteriaMicroorganism based processesBiotechnologyMicroorganism
The invention is applicable to the field of fish pathogenic microbiology, and provides a chromogenic solid culture medium of nocardia seriolae as well as preparation method and application. The chromogenic solid culture medium comprises the following components: brain heart leachate broth culture medium powder, agar powder, esculin, ferric citrate, an antibiotic composition, distilled water and culture supernatant of nocardia seriolae. The culture medium with the characteristics of short separation time, high sensitivity, high isolated bacterium purity, simple preparation method and the like can be prepared by adding the esculin, the ferric citrate, the culture supernatant of the nocardia seriolae in the logarithmic phase and the antibiotic composition on the basis of the basic formula ofthe brain heart leachate broth agar culture medium. The culture medium has the characteristics of high separation efficiency, high separation purity, convenience in observation and the like when beingused for separating nocardia seriola, and can be effectively applied to the separation of nocardia seriola in clinical sample.
Owner:SHENZHEN INST OF GUANGDONG OCEAN UNIV +2

Nocardioides as well as separation method and application thereof

ActiveCN113957019AIncrease diversityIncrease the fullness of smokeTobacco preparationBacteriaBiotechnologyNocardioides bigeumensis
The invention discloses nocardioides. The nocardioides is classified and named as nocardioides ST46 in microbiology, and is named as nocardioides sp. in Latin scientific name. The 16S rDNA partial sequence is as shown in a sequence table; and the preservation number of the strain is CGMCC 4.7686. The invention further discloses a culture and separation method of the nocardioides and application of the nocardioides in preparation of tobacco flavor. The nocardioides is a new strain, the tobacco flavor prepared from the nocardioides is used for flavoring cigarettes, the richness of tobacco flavor and the fullness of smoke are remarkably improved, the smoke strength is remarkably improved, and meanwhile, the aftertaste and comfort are good.
Owner:CHINA TOBACCO YUNNAN IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products